InnoCare Pharma Ltd.SSE: 688428

Announcement on Voluntary Disclosure of the Latest Research Results of Multiple Oncology Pipelines Selected for 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

· Issued by InnoCare Pharma Ltd. via Shanghai Stock Exchange

Filed with SSE ·

On 6ix: 6ix.com/news/announcement-on-voluntary-disclosure-of-the-latest-research-results-of-multiple-oncology-pipelines-selected-for-2025-american-society-of-clinical-oncology-asco-annual-meeting

Announcement on Voluntary Disclosure of the Latest Research Results of Multiple Oncology Pipelines Selected for 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

InnoCare Pharma Ltd. on 6ix

Earlier from InnoCare Pharma

Later from InnoCare Pharma

All InnoCare Pharma news releases